GBA1 and Parkinson disease: Overall, reduced CSF alpha-synuclein levels might reflect its accumulation in the brain, but further studies are warranted to better understand the meaning of alpha-synuclein changes in the CSF of PD patients carrying different pathogenic GBA1 mutations.